ASX - Delayed Quote • AUD PharmX Technologies Limited (PHX.AX) Follow Compare 0.0780 -0.0010 (-1.27%) At close: 3:21:52 PM GMT+11 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations January 2025 ASX Penny Stocks Spotlight The Australian market has shown modest growth, with the ASX200 rising by 0.2% to 8,273 points in afternoon trade, while sectors like IT and Telecommunications lead the way. Amid these movements, investors continue to explore various opportunities across different market segments. Penny stocks, though often considered a nostalgic term, remain relevant as they offer potential for growth at lower price points when backed by strong fundamentals. 3 Promising ASX Penny Stocks With A$30M Market Cap The Australian market has been experiencing mixed performance, with the ASX200 down 0.4% as investors react to disappointing Chinese stimulus measures and fluctuating commodity prices. Amidst these broader market conditions, penny stocks—though an older term—remain a relevant area for those seeking growth opportunities in smaller or newer companies. With strong financial foundations, these stocks can offer potential upside while mitigating some of the risks typically associated with this... PharmX Technologies Limited's (ASX:PHX) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? PharmX Technologies' (ASX:PHX) stock is up by a considerable 17% over the past week. Given that stock prices are... Why PharmX Technologies Limited (ASX:PHX) Could Be Worth Watching PharmX Technologies Limited ( ASX:PHX ), is not the largest company out there, but it saw a decent share price growth... A Look At The Fair Value Of PharmX Technologies Limited (ASX:PHX) Key Insights Using the 2 Stage Free Cash Flow to Equity, PharmX Technologies fair value estimate is AU$0.023 With... Performance Overview Trailing total returns as of 1/23/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] Return PHX.AX S&P/ASX 200 [XJO] YTD +5.41% +2.69% 1-Year +116.67% +11.49% 3-Year +37.46% +16.76%